Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Decision Aid to Technologically Enhance Shared Decision Making (DATES)

This study is currently recruiting participants. (see Contacts and Locations)
Verified December 2013 by University of Michigan
Sponsor:
Information provided by (Responsible Party):
Masahito Jimbo, MD, University of Michigan
ClinicalTrials.gov Identifier:
NCT01514786
First received: January 17, 2012
Last updated: December 9, 2013
Last verified: December 2013
  Purpose

Physicians face a challenge in promoting colorectal cancer screening (CRCS) in the face of multiple competing demands. A decision aid (DA) that clarifies patient preferences and improves decision quality could aid shared decision making (SDM) and be effective at increasing CRCS rates. However, exactly how such DA improves SDM is not clear. This 4-year R01 study funded by the National Cancer Institute seeks to provide detailed understanding of how an interactive DA affects patient-physician communication and SDM, and ultimately CRCS adherence.


Condition Intervention
Colorectal Cancer
Behavioral: Colorectal Web

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Single Blind (Subject)
Primary Purpose: Prevention
Official Title: Decision Aid to Technologically Enhance Shared Decision Making

Resource links provided by NLM:


Further study details as provided by University of Michigan:

Primary Outcome Measures:
  • The measurement of the impact of Colorectal Web on patient uptake of CRCS on patient determinants/preference/intention before the patient-physician encounter, and on SDM, concordance and patient intention during and after the patient-physician encounter. [ Time Frame: 6 months following intervention a chart audit will be conducted to determine if CRCS was completed. ] [ Designated as safety issue: No ]

Estimated Enrollment: 630
Study Start Date: May 2012
Estimated Study Completion Date: October 2014
Estimated Primary Completion Date: September 2014 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
No Intervention: Control
Same information is presented in the control website as is found in the intervention website, but no interactive component: preferences and risk assessment.
Active Comparator: Intervention with Colorectal Website
Intervention website includes an interactive component including preferences and risk assessment.
Behavioral: Colorectal Web
The intervention arm will allow participants on Colorectal Web to manipulate their preferences for CRCS

Detailed Description:

This two-armed randomized controlled trial (300 patients/arm) will compare Colorectal Web (CW), the interactive DA, to a non-interactive control website in ten practices in Metro Detroit. Patients will be adults aged 50 years and over, not current on CRCS. In the clinic before the patient-physician encounter, participants will complete a Patient Baseline Survey. They will be randomized to CW or the control website. Data will be collected after the patient reviews the respective website (Post-Intervention Survey), during the patient-physician encounter (digital audio recording), and after it (Post-Encounter Survey). Chart audit will be performed six months after the encounter to determine whether the patient underwent CRCS.

  Eligibility

Ages Eligible for Study:   50 Years to 75 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • 50-75 years of age
  • not current with colorectal cancer screening
  • scheduled for HME, Health Maintenance Exam, or chronic care visit with participating physician
  • able to read English
  • current contact information

Exclusion Criteria:

  • history of colon cancer or adenomatous polyps
  • history of dementia or psychosis
  • contraindication to CRCS
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01514786

Contacts
Contact: Mary Rapai, MA 734-998-7120 ext 343 mrapai@umich.edu

Locations
United States, Michigan
Children's and Family Medical Clinic Recruiting
Allen Park, Michigan, United States, 48101
Contact: Mary Rapai, MA    734-998-7120 ext 343    mrapai@umich.edu   
Downriver Internists Recruiting
Allen Park, Michigan, United States, 48101
Contact: Mary Rapai, MA    734-998-7120 ext 343    mrapai@umich.edu   
University of Michigan Briarwood Family Medicine Recruiting
Ann Arbor, Michigan, United States, 48108
Contact: Mary Rapai, MA    734-998-7120 ext 343    mrapai@umich.edu   
University of Michigan Family Medicine at Domino's Recruiting
Ann Arbor, Michigan, United States, 48106
Contact: Mary Rapai, MA    734-998-7120    mrapai@umich.edu   
Dua Family Practice Recruiting
Canton, Michigan, United States, 48187
Contact: Mary Rapai, MA    734-998-7120 ext 343    mrapai@umich.edu   
George C. Hawrot, MD Recruiting
Dearborn, Michigan, United States, 48124
Contact: Mary Rapai, MA    734-998-7120 ext 343    mrapai@umich.edu   
Morang Chester Clinic Recruiting
Detroit, Michigan, United States, 48224
Contact: Mary Rapai, MA    734-998-7120 ext 343    mrapai@umich.edu   
David Williams, MD Recruiting
Detroit, Michigan, United States, 48235
Contact: Mary Rapai, MA    734-998-7120 ext 343    mrapai@umich.edu   
Rice Lanzilote & Egan Recruiting
Detroit, Michigan, United States, 48227
Contact: Mary Rapai, MA    734-998-7120 ext 343    mrapai@umich.edu   
Andrew Thomas, MD Recruiting
Detroit, Michigan, United States, 48201
Contact: Mary Rapai, MA    734-998-7120 ext 343    mrapai@umich.edu   
IPC - Livonia Internal Medicine Recruiting
Livonia, Michigan, United States, 48152
Contact: Mary Rapai, MA    734-998-7120 ext 343    mrapai@umich.edu   
Lonnie Joe Jr. MD Recruiting
Southfield, Michigan, United States, 48075
Contact: Mary Rapai, MA    734-998-7120 ext 343    mrapai@umich.edu   
Mark W. Sawka, MD Recruiting
Woodhaven, Michigan, United States, 48183
Contact: Mary Rapai, MA    734-998-7120 ext 343    mrapai@umich.edu   
University of Michigan Family Medicine at Corner Health Center Recruiting
Ypsilanti, Michigan, United States, 48197
Contact: Mary Rapai, MA    734-998-7120 ext 343    mrapai@umich.edu   
Sponsors and Collaborators
University of Michigan
Investigators
Principal Investigator: Masahito Jimbo, MD, PhD, MPH University of Michigan
  More Information

No publications provided by University of Michigan

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Masahito Jimbo, MD, Clinical Associate Professor, Family Medicine, University of Michigan
ClinicalTrials.gov Identifier: NCT01514786     History of Changes
Other Study ID Numbers: HUM00044733
Study First Received: January 17, 2012
Last Updated: December 9, 2013
Health Authority: United States: Institutional Review Board

Keywords provided by University of Michigan:
Colorectal Cancer
Screening
Prevention

Additional relevant MeSH terms:
Colorectal Neoplasms
Colonic Diseases
Digestive System Diseases
Digestive System Neoplasms
Gastrointestinal Diseases
Gastrointestinal Neoplasms
Intestinal Diseases
Intestinal Neoplasms
Neoplasms
Neoplasms by Site
Rectal Diseases

ClinicalTrials.gov processed this record on November 25, 2014